Triple GIP/GLP-1/glucagon receptor agonist. CAS 2381089-83-2. 36mg/3ml vial, 108mg total API. Store 2-8°C.
Retatrutide is a synthetic triple receptor agonist (GIP/GLP-1/glucagon) studied for its combined effects across incretin and glucagon-signaling pathways. As a newer compound, researchers should confirm compound identity against the batch-specific COA and mass spec report.
Every unit ships with a batch-specific Certificate of Analysis documenting purity, identity confirmation, appearance, and lot number.
Purity 98.5% · Identity confirmed
Third-party verification is available on request for wholesale and institutional buyers. Contact wholesale@marquepeptides.com.
Reconstitute with bacteriostatic water (BAC) at a concentration appropriate for your research protocol. Do not vortex; gently swirl until fully dissolved.
Handle in a clean laboratory environment. Use appropriate PPE (gloves, lab coat, eye protection). Refer to the MSDS included with your shipment for complete safety guidance.